Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Dinara Mesitskaya"'
Autor:
Nana Gogiberidze, Aleksandr Suvorov, Elizaveta Sultygova, Zhanna Sagirova, Natalia Kuznetsova, Daria Gognieva, Petr Chomakhidze, Victor Frolov, Aleksandra Bykova, Dinara Mesitskaya, Alena Novikova, Danila Kondakov, Alexey Volovchenko, Stefano Omboni, Philippe Kopylov
Publikováno v:
Pathophysiology, Vol 30, Iss 4, Pp 586-598 (2023)
It would be useful to develop a reliable method for the cuffless measurement of blood pressure (BP), as such a method could be made available anytime and anywhere for the effective screening and monitoring of arterial hypertension. The purpose of thi
Externí odkaz:
https://doaj.org/article/5589f026c6154c999c7f62ea6251bb94
Autor:
Svetlana Tarasenko, Maria Poltavskaya, Kristina Charaya, Dmitry Shchekochikhin, Denis Andreev, Irina Dyachuk, Dinara Mesitskaya, Alexandra Bogdanova, Natalia Ananicheva, Alina Kuzub
Publikováno v:
Open Heart, Vol 9, Iss 1 (2022)
Externí odkaz:
https://doaj.org/article/5fa8f0e13112465fbc1d339fdc21aa5f
Autor:
Daria Gognieva, Nelly Vishnyakova, Yulia Mitina, Petr Chomakhidze, Dinara Mesitskaya, Natalia Kuznetsova, Mohamed Khiari, Galina Ryabykina, Sergey Boytsov, Abram Syrkin, Hugo Saner, Philipp Kopylov
Publikováno v:
Global Heart, Vol 17, Iss 1 (2022)
Background: Screening for atrial fibrillation has the potential to significantly reduce cardiovascular morbidity and mortality. However, questions in regard to how to screen, on whom to screen, and the optimal setting of screening remain unanswered.
Externí odkaz:
https://doaj.org/article/aa52773eead946169a112df75b95baae
Autor:
Kristina Charaya, Dmitry Shchekochikhin, Denis Andreev, Irina Dyachuk, Svetlana Tarasenko, Maria Poltavskaya, Dinara Mesitskaya, Alexandra Bogdanova, Natalia Ananicheva, Alina Kuzub
Publikováno v:
Open Heart. 9:e001936
ObjectiveTo determine the impact of sodium-dependent glucose type 2 cotransporter inhibitors on the renal function in acute heart failure.MethodsIn a single-centre, controlled, randomised study, patients were prescribed dapagliflozin in addition to s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab0934e1c21b594426128e41eac55c02
https://doi.org/10.1136/openhrt-2021-001936
https://doi.org/10.1136/openhrt-2021-001936
Publikováno v:
Терапевтический архив, Vol 86, Iss 9, Pp 77-82 (2014)
Scopus-Elsevier
Scopus-Elsevier
AIM. To analyze the influence of clinical and pharmacogenetic factors on the risk of resistance to original or generic clopidogrel and that of cardiovascular events (CVE) during 12 months of follow-up. MATERIALS AND METHODS. Two hundred and fifty pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::2bc095870a38a33afb26cdacf97247be
https://ter-arkhiv.ru/0040-3660/article/view/31571
https://ter-arkhiv.ru/0040-3660/article/view/31571